We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current COGT market cap is 801.17M. The company's latest EPS is USD -1.8516 and P/E is -1.27.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -36.82M | -43.75M | -43.24M | -47.09M | -59.58M |
| Net Income | -35.06M | -39.62M | -38.59M | -44.08M | -55.38M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 22.5M | 7.87M | 0 | 0 | 0 |
| Operating Income | -32.18M | -82.2M | -75.55M | -147.84M | -208.13M |
| Net Income | -31.83M | -74.81M | -72.27M | -140.24M | -192.41M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 331.56M | 300.81M | 263.2M | 392.37M | 355.45M |
| Total Liabilities | 41.62M | 45.08M | 39.64M | 43.94M | 52.55M |
| Total Equity | 289.94M | 255.74M | 223.56M | 348.43M | 302.9M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 49.42M | 250.92M | 232.09M | 300.81M | 313.44M |
| Total Liabilities | 17.66M | 16.25M | 17.91M | 45.08M | 55.64M |
| Total Equity | 31.76M | 234.67M | 214.18M | 255.74M | 257.8M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -89.23M | -118.64M | -39.52M | -71.58M | -109.55M |
| Investing | -153.13M | -124.72M | 59.88M | -17.78M | -108.31M |
| Financing | 163.24M | 163.56M | 445k | 162.54M | 163.54M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -41.51M | -35.85M | -58.76M | -118.64M | -153.62M |
| Investing | 23.16M | 8.42M | -1.72M | -124.72M | -97.82M |
| Financing | 108k | 232.2M | 37.98M | 163.56M | 163.54M |
| Market Cap | 801.17M |
| Price to Earnings Ratio | -1.27 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.59 |
| Price to Book Ratio | 0.95 |
| Dividend Yield | - |
| Shares Outstanding | 103.91M |
| Average Volume (1 week) | 1.65M |
| Average Volume (1 Month) | 1.38M |
| 52 Week Change | -28.94% |
| 52 Week High | 13.50 |
| 52 Week Low | 3.67 |
| Spread (Intraday) | 0.93 (11.97%) |
| Company Name | Cogent Biosciences Inc |
| Address |
838 walker road dover, delaware 19904 |
| Website | https://www.unumrx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
